| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Ellis Christopher is a Chief Operating Officer at Barinthus Biotherapeutics plc.. Recent SEC Form 4 filings include 1 buy and 8 sells.
Estimated insider holdings value: $26K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2022 | BRNS Barinthus Biotherapeutics Plc. | Chief Operating Officer | Sale+OE | 39,626 | $6.55 | $259,548.09 | -61.1% | -61.6% | -67.4% | |
| Aug 18, 2022 | BRNS Barinthus Biotherapeutics Plc. | Chief Operating Officer | Sale+OE | 2,824 | $4.82 | $13,623.66 | -95.0% | -48.8% | -58.0% | |
| Aug 16, 2022 | BRNS Barinthus Biotherapeutics Plc. | Chief Operating Officer | Sale+OE | 7,550 | $4.77 | $35,976.47 | -98.1% | -48.9% | -57.0% | |
| Jun 28, 2022 | BRNS Barinthus Biotherapeutics Plc. | Chief Operating Officer | Sale+OE | 5 | $6.00 | $30.00 | -6.3% | -41.5% | -57.1% | |
| May 4, 2021 | BRNS Barinthus Biotherapeutics Plc. | Chief Operating Officer | Buy | 75 | $17.00 | $1,275.00 | New | +14.1% | -62.1% |